InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by Bobulsky Susan. Director active across 1 company, notably Adaptive Biotechnologies Corp. Cumulatively, 12 disclosures have been recorded. Split: 0 buy · 8 sells. Total volume traded: €841k. Activity tracked since 4 March 2024. The latest transaction was filed on 10 August 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 条申报中的 12 条
Susan Bobulsky is a declarant linked to Adaptive Biotechnologies Corp, where she holds the role of Chief Commercial Officer, MRD. She has made 11 filings in total, and across the 11 sampled filings, the transactions are all sales, for EUR 776225 between 2024-03-06 and 2026-08-03.